Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for OMER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 286.83M
March 31, 2026 286.17M
December 31, 2025 325.63M
September 30, 2025 185.71M
June 30, 2025 200.57M
March 31, 2025 235.16M
December 31, 2024 277.08M
September 30, 2024 313.34M
June 30, 2024 356.31M
March 31, 2024 437.49M
December 31, 2023 378.27M
September 30, 2023 493.07M
June 30, 2023 527.42M
March 31, 2023 560.13M
December 31, 2022 590.97M
September 30, 2022 457.55M
June 30, 2022 345.64M
March 31, 2022 369.26M
December 31, 2021 419.27M
September 30, 2021 123.43M
June 30, 2021 145.39M
March 31, 2021 161.44M
December 31, 2020 181.04M
September 30, 2020 227.08M
June 30, 2020 70.69M
Date Value
March 31, 2020 118.21M
December 31, 2019 136.97M
September 30, 2019 91.26M
June 30, 2019 89.76M
March 31, 2019 101.25M
December 31, 2018 95.94M
September 30, 2018 75.61M
June 30, 2018 106.35M
March 31, 2018 89.04M
December 31, 2017 116.33M
September 30, 2017 125.52M
June 30, 2017 60.35M
March 31, 2017 58.40M
December 31, 2016 67.28M
September 30, 2016 72.76M
June 30, 2016 46.11M
March 31, 2016 35.97M
December 31, 2015 49.00M
September 30, 2015 41.42M
June 30, 2015 58.64M
March 31, 2015 74.91M
December 31, 2014 11.09M
September 30, 2014 25.29M
June 30, 2014 40.99M
March 31, 2014 56.07M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 142.28B
Talphera, Inc. 26.81M
Hyperion DeFi, Inc. 113.14M
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M

Total Assets (Quarterly) Related Metrics